Experts seek painkiller ban

Last updated 05:00 14/02/2013

Relevant offers

Health

Probing the differences in brain activity may help people with depression Matamata Medical Centre cops criticism High rate of maori infants suffering sudden deaths prompts Hutt Valley hui Nearly a quarter of NZ women drink after realising they are pregnant - study Is new female sexual desire drug Flibanserin worth getting excited about? Thousands rejected for elective surgery assessment in Canterbury Mother and disabled son offered house after five months Rheumatic fever prevention programmes making inroads Reduced home management support for Manawatu elderly Euthanasia inquiry to look at international cases and reasons for wanting to die

A popular painkiller should be banned worldwide because it raises the risk of heart attack and stroke by almost half, British academics say.

Risks from diclofenac, widely sold as Voltaren, were highest in those who used it regularly, and safer options were available, they said.

Medsafe in New Zealand said it would consider the research, but noted previous reviews had shown its benefits outweighed potential risks.

Diclofenac is a non-steroidal anti-inflammatory drug often prescribed after surgery or to combat arthritic pain when other painkillers are not strong enough.

It has been available in New Zealand for more than 20 years. I

t is subsidised by state drug-buying agency Pharmac, with 375,000 people being prescribed it in the year ending November 2012. That figure does not include those who buy it over the counter.

Ad Feedback

- The Dominion Post

Special offers
Opinion poll

Should fluoride in water be the responsibility of central government?

Yes

No

Vote Result

Featured Promotions

Sponsored Content